Policy Outlook: Understanding the Environment for Pricing and Access to Medicines During an Election Year
Tuesday, February 27, 2024
As Congressional and Presidential elections approach, pricing and access to medicines are topics of great interest and debate to different constituencies. Attend this conversation among dynamic stakeholders to review the impact of prescription drug affordability boards in states, reimbursement pathways for novel therapeutics, and how federal rulemaking all impact the future and financing of R&D in the industry.
SpeakersMichael Ward, Vice President of Public Policy and Government Relations - Alliance for Aging ResearchRick Weissenstein, Managing Director, Washington Research Group - Health Care Services & Pharmaceutical Policy - TD Cowen Washington Research Group